China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIGet Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the stock.

China Pharma Price Performance

NYSE:CPHI opened at $0.10 on Monday. China Pharma has a 52 week low of $0.09 and a 52 week high of $0.67. The firm has a 50 day moving average of $0.13 and a 200 day moving average of $0.19. The stock has a market capitalization of $5.41 million, a price-to-earnings ratio of -1.31 and a beta of 0.65.

China Pharma Company Profile

(Get Rating)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Read More

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.